Industry › BioTech
Press Releases
BioMed X Launches a New Call for Application in Autoimmune Disease Research
BioMed X Institute
Nov 07, 2023 19:00 HKT/SGT
Acrometa Group Signs MOU for Sand Concession, Opening New Business Opportunities in the Region
AcroMeta Group Limited
Nov 06, 2023 21:00 HKT/SGT
DC Healthcare Unveils Innovative Skincare Range 'newB' Under Subsidiary Ten Doctors Sdn Bhd
DC Healthcare
Nov 01, 2023 19:00 HKT/SGT
BioMed X and AbbVie Start New Research Project in the USA
BioMed X Institute
Nov 01, 2023 07:00 HKT/SGT
Acrometa to Focus on Laboratory Construction and Co-Working Laboratory Space Business
AcroMeta Group Limited
Oct 31, 2023 21:00 HKT/SGT
Namwiwat Medical Corporation Plc (NAM) enjoys first day on SET
Namwiwat Medical Corporation PCL
Oct 31, 2023 20:00 HKT/SGT
EW Healthcare Partners Acquires Stake in Boiron Group, a Leader in Natural Medicine
EW Healthcare Partners
Oct 27, 2023 21:00 HKT/SGT
LEQEMBI (lecanemab-Irmb) Named One of Time's Best Inventions of 2023
Eisai
Oct 25, 2023 19:43 HKT/SGT
四环医药（0460.HK）旗下轩竹生物自主研发吡罗西尼单药II期试验入选2023 ESMO 为晚期HR+/HER2-乳腺癌患者提供了新思路
Sihuan Pharmaceutical Holdings Group Ltd.
Oct 24, 2023 10:50 HKT/SGT
四環醫藥（0460.HK）：旗下軒竹生物自主研發吡羅西尼單藥II期試驗入選2023 ESMO 重磅臨床試驗結果再次登上國際舞台
Sihuan Pharmaceutical Holdings Group Ltd.
Oct 24, 2023 10:49 HKT/SGT
아방스 클리니컬, 45개의 한국 생명 공학 기업 초청해 한국과 호주에서 미국으로 이어지는 글로벌레디 신약 개발 경로에 대한 설명회 개최
Avance Clinical
Oct 19, 2023 18:00 HKT/SGT
アバンセ・クリニカル、招待を受け、韓国バイオ企業45社に韓国・オーストラリアから米国へのGlobalReady医薬品開発経路を説明
Avance Clinical
Oct 19, 2023 12:00 JST
Avance Clinical Invited to Brief 45 Korean Biotechs on Their GlobalReady Drug Development Pathway from Korea and Australia to the US
Avance Clinical
Oct 19, 2023 09:00 HKT/SGT
四环医药（0460.HK）：旗下轩竹生物自主研发治疗晚期乳腺癌新药上市申请获国家药监局受理
Sihuan Pharmaceutical Holdings Group Ltd.
Oct 17, 2023 16:03 HKT/SGT
四環醫藥（0460.HK）：旗下軒竹生物自主研發治療晚期乳腺癌新藥上市申請獲國家藥監局受理
Sihuan Pharmaceutical Holdings Group Ltd.
Oct 17, 2023 16:02 HKT/SGT
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical: The NDA of the New Drug, independently developed for the treatment of advanced breast cancer was accepted by NMPA
Sihuan Pharmaceutical Holdings Group Ltd.
Oct 17, 2023 16:01 HKT/SGT